Obesity
Showing NaN - NaN of 47
Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Goodyear, Arizona
- +36 more
Sep 29, 2017
Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- +2 more
- liraglutide
- placebo
-
Glendale, California
- +41 more
Sep 29, 2017
Obesity Trial in Atlanta (Diet/Nutrition Education)
Completed
- Obesity
- Diet/Nutrition Education
-
Atlanta, GeorgiaKaiser Permanente Center for Health Research, Southeast
Aug 15, 2017
Overweight, Obesity Trial in Atlanta (KP Personal Shopper Visits, In-Office Dietitian Visits)
Completed
- Overweight
- Obesity
- KP Personal Shopper Visits
- In-Office Dietitian Visits
-
Atlanta, GeorgiaKaiser Permanente Center for Health Research, Southeast
Mar 1, 2017
Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)
Terminated
- Obesity
- Cardiovascular Diseases
- Naltrexone HCl/Bupropion HCl ER
- Placebo
-
Alexander City, Alabama
- +138 more
Feb 21, 2017
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016
Autism, Obesity Trial in Atlanta (Parent Education Program, Manual-based Behavioral Treatment)
Completed
- Autism
- Obesity
- Parent Education Program
- Manual-based Behavioral Treatment
-
Atlanta, GeorgiaPediatric Feeding Disorders Program at the Marcus Autism Center
Jan 19, 2016
Diabetes, Hypertension, Obesity Trial in Atlanta (Intralipid 20%, Normal Saline, Oral fat load)
Completed
- Diabetes
- +2 more
- Intralipid 20%
- +2 more
-
Atlanta, GeorgiaGrady Memorial Hospital
Jul 23, 2015
Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)
Completed
- Obesity
- Placebo
- Pramlintide and Metreleptin
-
Birmingham, Alabama
- +32 more
Mar 26, 2015
Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)
Completed
- Overweight
- Obesity
- pramlintide acetate
- +3 more
-
Birmingham, Alabama
- +35 more
Mar 26, 2015
Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360
Completed
- Obesity
- Overweight
- Naltrexone SR 16 mg/Bupropion SR 360 mg /day
- +3 more
-
Birmingham, Alabama
- +33 more
Nov 18, 2014
Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)
Completed
- Obesity
- Overweight
- Naltrexone SR 32 mg/bupropion SR 360 mg/day
- +2 more
-
Phoenix, Arizona
- +35 more
Nov 18, 2014
Partnership Programs to Reduce Ethnic Differences in Risk of
Completed
- Cardiovascular Diseases
- +3 more
-
Atlanta, Georgia
- +1 more
Sep 12, 2014
Obesity, Diabetes Trial in Atlanta (home-delivered meals, diabetes education for 12 months)
Terminated
- Obesity
- Diabetes
- home-delivered meals
- diabetes education for 12 months
-
Atlanta, GeorgiaGrady Health System
Jun 7, 2014
Obesity Trial in Atlanta (Mediterranean Diet, Mediterranean Dietary Supplement)
Completed
- Obesity
- Mediterranean Diet
- Mediterranean Dietary Supplement
-
Atlanta, GeorgiaEmory University Hospital
Nov 15, 2013
Diabetes, Obesity Trial in Atlanta (Lifestyle Intervention Classes)
Completed
- Diabetes
- Obesity
- Lifestyle Intervention Classes
-
Atlanta, GeorgiaEmory University
Sep 24, 2013
Obesity Trial in Canada, United States (CP-945,598 Treatment A, CP-945,598 Treatment B, Placebo)
Terminated
- Obesity
- CP-945,598 Treatment A
- +2 more
-
Fairhope, Alabama
- +81 more
Nov 5, 2012
Insulin Resistance in Severely Obese Patients
Completed
- Obesity
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Mar 17, 2010
Obesity, Weight Loss Trial in Canada, United States (Rimonabant (SR141716))
Completed
- Obesity
- Weight Loss
- Rimonabant (SR141716)
-
Birmingham, Alabama
- +50 more
Apr 17, 2009
Obesity Trial in United States (Nasal Placebo, Placebo Capsule, PYY3-36)
Completed
- Obesity
- Nasal Placebo
- +3 more
-
Peoria, Arizona
- +28 more
Sep 12, 2008